[Hospital pharmacist has a rule for best practice use and French hospital activity tariffs. Example of a pharmaceutical quality control for drugs reimbursed in addition of DRGs]. / Le pharmacien hospitalier au cÅur des enjeux du bon usage des médicaments et de la tarification à l'activité. Exemple d'une organisation de contrôle qualité pharmaceutique pour le remboursement des médicaments en sus des GHS.
Ann Pharm Fr
; 70(4): 188-98, 2012 Jul.
Article
en Fr
| MEDLINE
| ID: mdl-22818260
ABSTRACT
The best practice contract has given a new objective to the hospital pharmacists for the reimbursement in addition to Diagnosis Related Groups' (DRGs) tariffs. We built our pharmaceutical quality control for the administration traceability follow-up regarding the DRGs and the cost of care, for two reasons the nominal drugs dispensation in link with the prescription made by pharmacist and the important expenditure of these drugs. Our organization depends on the development level of the informatized drugs circuit and minimizes the risk of financial shortfalls or wrong benefits, possible causes of economic penalties for our hospital. On the basis of this follow-up, we highlighted our activity and identified problems of management and drugs circuit organization. The quality of the administration traceability impacts directly on the quality of the medical records and the reimbursements of the expensive drugs. A better knowledge of prescription software is also required for a better quality and security of the medical data used in the medical informatic systems. The drugs management and the personal treatment in and between the care units need to be improved too. We have to continue and improve our organization with the future financial model for ATU drugs and the FIDES project. The health personnel awareness and the development of best informatic tools are also required.
Texto completo:
1
Base de datos:
MEDLINE
Asunto principal:
Farmacéuticos
/
Servicio de Farmacia en Hospital
/
Control de Calidad
/
Grupos Diagnósticos Relacionados
Tipo de estudio:
Guideline
/
Prognostic_studies
País/Región como asunto:
Europa
Idioma:
Fr
Revista:
Ann Pharm Fr
Año:
2012
Tipo del documento:
Article